By Stewart Eisenhart, Emergo Group
Brazil’s medical device regulator ANVISA is nearing implementation of a new “notification” market pathway for low-risk devices.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.